MX2021010350A - Composicion que comprende leuconostoc citreum wikim0104 para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso. - Google Patents

Composicion que comprende leuconostoc citreum wikim0104 para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso.

Info

Publication number
MX2021010350A
MX2021010350A MX2021010350A MX2021010350A MX2021010350A MX 2021010350 A MX2021010350 A MX 2021010350A MX 2021010350 A MX2021010350 A MX 2021010350A MX 2021010350 A MX2021010350 A MX 2021010350A MX 2021010350 A MX2021010350 A MX 2021010350A
Authority
MX
Mexico
Prior art keywords
liver disease
fatty liver
wikim0104
composition
leuconostoc citreum
Prior art date
Application number
MX2021010350A
Other languages
English (en)
Inventor
Hak-Jong CHOI
Seul-Ki Lim
Original Assignee
Korea Food Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Food Res Inst filed Critical Korea Food Res Inst
Publication of MX2021010350A publication Critical patent/MX2021010350A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/31—Leuconostoc
    • A23V2400/315—Citreum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Birds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un nuevo Leuconostoc citreum WiKim0104 aislado del Kimchi y a una composición que comprende el mismo o su uso. La presente invención proporciona un método para la prevención, mejora y tratamiento de la inflamación, la obesidad o la enfermedad del hígado graso de un sujeto mediante la administración del nuevo Leuconostoc citreum WiKim0104 aislado del Kimchi o de una composición que comprende el mismo. El Leuconostoc citreum WiKim0104 de acuerdo con la presente invención muestra un efecto inhibitorio sobre la producción de hígado graso mediante la inhibición de la acumulación de grasa en las células hepáticas y la reducción de la expresión de los genes relacionados con el hígado graso, por lo tanto puede utilizarse de diversas formas para usos en la prevención, mejora y tratamiento de la inflamación, la obesidad o la enfermedad del hígado graso.
MX2021010350A 2019-02-28 2020-02-27 Composicion que comprende leuconostoc citreum wikim0104 para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso. MX2021010350A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190024254A KR102032982B1 (ko) 2019-02-28 2019-02-28 류코노스톡 시트래움 WiKim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물
PCT/KR2020/002845 WO2020175940A1 (ko) 2019-02-28 2020-02-27 류코노스톡 시트래움 wikim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물

Publications (1)

Publication Number Publication Date
MX2021010350A true MX2021010350A (es) 2022-01-06

Family

ID=68421541

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010350A MX2021010350A (es) 2019-02-28 2020-02-27 Composicion que comprende leuconostoc citreum wikim0104 para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso.

Country Status (10)

Country Link
US (1) US20220047652A1 (es)
EP (1) EP3933031A4 (es)
JP (1) JP7201837B2 (es)
KR (1) KR102032982B1 (es)
CN (1) CN113498433B (es)
AU (1) AU2020228247A1 (es)
BR (1) BR112021016879A2 (es)
CA (1) CA3131258A1 (es)
MX (1) MX2021010350A (es)
WO (1) WO2020175940A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102032982B1 (ko) * 2019-02-28 2019-10-16 한국식품연구원 류코노스톡 시트래움 WiKim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물
KR20220091428A (ko) 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 류코노스톡 시트리움 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물
WO2022139531A1 (ko) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 류코노스톡 시트리움 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물
US20240091281A1 (en) * 2021-02-08 2024-03-21 Hwa Sup CHIN Pharmaceutical composition for preventing or treating intestinal damage comprising leuconostoc citreum strain as active ingredient
CA3207792A1 (en) * 2021-02-08 2022-08-11 Hwa Sup Chin Pharmaceutical composition for preventing or treating cholestatic liver injury comprising leuconostoc citreum strain as active ingredient
CA3207719A1 (en) * 2021-02-08 2022-08-11 Hwa Sup Chin Pharmaceutical composition for preventing or treating fibrosis comprisi ng leuconostoc citreum strain as active ingredient
KR102390715B1 (ko) * 2021-07-13 2022-04-29 한국식품연구원 류코노스톡 시트리움 WiKim0129를 포함하는 암의 예방, 개선 또는 치료용 조성물
CN115380998B (zh) * 2022-05-17 2023-07-07 西北工业大学 可获得改善人肝纤维化天然功能羊奶的奶山羊全混合日粮

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100872911B1 (ko) * 2007-10-25 2008-12-10 두두원발효(주) 김치유산균으로 발효한 콩 요구르트를 유효성분으로함유하는 비만억제용 조성물
KR20100037310A (ko) * 2008-10-01 2010-04-09 주식회사 비티엠 김치 유산균을 이용한 액상 건강보조식품의 제조방법
AU2011262840B2 (en) * 2010-06-08 2015-02-05 Asahi Group Holdings, Ltd. Lipid metabolism-improving agent
KR101704126B1 (ko) * 2014-06-12 2017-02-07 동국대학교 경주캠퍼스 산학협력단 아스퍼질러스 우사미 및 류코노스톡 시트륨 균주를 이용한 진세노사이드 함량이 증가된 홍삼 제제 및 이의 제조방법
KR20160108645A (ko) 2015-03-04 2016-09-20 을지대학교 산학협력단 발효 두유 쏘이프로 상층액의 항염 효과 기능성 조성물 및 그 제조 방법
KR20170000510A (ko) * 2015-06-24 2017-01-03 주식회사 대유위니아 항비만 유산균의 발생을 위한 김치의 숙성방법 및 이것이 프로그래밍된 냉장고
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
KR101838280B1 (ko) * 2017-05-30 2018-03-14 한국식품연구원 관절염의 개선 활성을 갖는 류코노스톡 시트리움 wikim56 및 이를 포함하는 조성물
KR102390405B1 (ko) 2017-08-31 2022-04-25 한화테크윈 주식회사 도어벨 장치
KR102032982B1 (ko) * 2019-02-28 2019-10-16 한국식품연구원 류코노스톡 시트래움 WiKim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물

Also Published As

Publication number Publication date
CA3131258A1 (en) 2020-09-03
AU2020228247A1 (en) 2021-09-30
CN113498433B (zh) 2024-04-05
JP2022522300A (ja) 2022-04-15
KR102032982B1 (ko) 2019-10-16
BR112021016879A2 (pt) 2021-11-03
WO2020175940A1 (ko) 2020-09-03
CN113498433A (zh) 2021-10-12
EP3933031A4 (en) 2023-02-15
US20220047652A1 (en) 2022-02-17
EP3933031A1 (en) 2022-01-05
JP7201837B2 (ja) 2023-01-10

Similar Documents

Publication Publication Date Title
MX2021010350A (es) Composicion que comprende leuconostoc citreum wikim0104 para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso.
MX2021010349A (es) Composicion para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso que comprende la weissella hellenica wikim0103.
MX2017009532A (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
MX2022004102A (es) Composiciones de oligonucleotidos y metodos de uso de las mismas.
EP4219713A3 (en) Products and compositions
SA519400950B1 (ar) Masp-3 تركيبات وطرق لتثبيط لعلاج أمراض واضطرابات مختلفة
MX2014010161A (es) Nanoestructuras para tratar cancer y otras afecciones.
WO2018084531A3 (ko) 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
PH12021550985A1 (en) Vesicles derived from lactobacillus paracasei and use of same
SA519410204B1 (ar) تركيبة تستهدف s1pr4 من أجل الوقاية من التهاب الكبد الدهني غير الكحولي أو علاجه
MX2023001450A (es) Composiciones y metodos para la inhibicion de la expresion de plp1.
NZ756936A (en) Composition and method for preventing or delaying onset of myopia comprising atropine
WO2019045287A3 (ko) 찔레열매 추출물의 분획물을 유효성분으로 포함하는 면역 질환의 예방, 개선 또는 치료용 조성물
MX2016008102A (es) Composiciones y métodos para tratar la acumulacion de tejido graso.
MX2021006784A (es) Constructos de arni para inhibir la expresion de pnpla3 y metodos de uso de estos.
WO2019031729A3 (ko) 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 비알콜성 단순 지방간 또는 비알콜성 지방간염의 개선 용도
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
MX2020008991A (es) Metodos para alterar la composicion corporal.
MY193613A (en) Synergistic composition for osteoarthritis
MX2019002579A (es) Composiciones y metodos de uso de depuradores de gamma-cetoaldehido para tratar, evitar o mejorar la enfermedad del higado graso no alcoholico (nafld), nash, ald o condiciones relacionadas al higado.
MX2016012127A (es) Ostreolisina, variante de la misma funcionalmente relacionada, extracto que comprende ostreolisina y usos de los mismos.
WO2019017677A3 (ko) 시트랄을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물
WO2019027244A3 (ko) 양춘사 추출물을 함유하는 지방간 예방 및 치료 개선 조성물
MX2022015552A (es) Prevencion, reduccion o mejora del olor a persona mayor.
WO2016190689A3 (ko) 근육 질환 예방, 개선 또는 치료용 또는 근 기능 개선용 조성물